β‘ This is your brand? Claim your page FREE and bring it to life on AI search.
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Belumosudil (KD025) ROCK inhibitor Mesylate just got measured.
4/10 means Belumosudil (KD025) ROCK inhibitor Mesylate is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
G Smoothened Agonist Belumosudil (KD025) PDGFR 740Y-P TAK-243 (MLN7243) Vactosertib (TEW-7197) Tirzepatide (LY3298176) Scroll down to content Belumosudil (KD025) ROCK inhibitor Mesylate Belumosudil (KD025) Mesylate: A Selective ROCK2 Inhibitor for Advanced Research A B S T R A C T Belumosudil (KD025) is a potent, selective orally bioavailable inhibitor of Rho-associated coiled-coil kinase 2 (ROCK2
Industry: Healthcare
hitthepass.com1
Structured Data
3
Content Structure
5
Entity Clarity
5
E-E-A-T Signals
5
Technical AEO
2
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Belumosudil (KD025) ROCK inhibitor Mesylate.
Scored by Engagemii on June 28, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/hitthepass
Cite this score: Engagemii (2026). "AEO Score for Belumosudil (KD025) ROCK inhibitor Mesylate." Retrieved from https://engagemii.com/aeo/brands/hitthepass
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform